Gapping up
In reaction to strong earnings/guidance:
- FUN +13.2% (outlines COVID-19 response; withdraws long-term financial guidance; suspends quarterly distribution), TSG +12.7%, STT +7.1%, UBER +5.7% (withdraws 2020 guidance), SLB +4.1%, WAL +3.8%, ISRG +3.2%, RF +2.5%, MUSA +1.9%, AMWD +1.8% (withdraws fiscal 2020 outlook), IBKC +1.3%
Select index ETFs showing strength:
- IWM +4.9%, DIA +3.2%, SPY +2.9%, QQQ +1.9%
Other news:
- CEQP +20.9% (maintains distribution of $0.625 per unit; reduces cap-ex by over $40 mln)
- MRNA +18% (announces award from US govt to accelerate development of the co's mRNA vaccine candidate),
- BCRX +16.2% (in sympathy with GILD)
- HCM +15.5% (receives Fast Track Designations for Surufatinib)
- GILD +11.8% (early trial data said to suggest that COVID-19 patients are responding to treatment with remdesivir, according to Stat News)
- BA +9.1% (to resume production of Commercial Airplanes in Puget Sound facilities next week)
- JWN +7.6% (announces additional measures to strengthen its financial position)
- JACK +7.2% (names new CEO)
- MESO +6% (to present positive clinical outcomes using remestemcel-L in patients with inflammatory lung disease at 2020 International Society of Cell and Gene Therapy Meeting)
- EOLS +5.6% (announces pre-emptive plan to support US aesthetic neurotoxin market in light of the COVID-19 pandemic)
- TXT +5.5% (awarded $390 mln Navy contract)
- TGT +1.8% (enters into $900 mln unsecured revolving credit facility)
Analyst comments:
- LOVE +17.2% (upgraded to Buy from Hold at Stifel)
- WOW +8.9% (upgraded to Overweight from Sector Weight at KeyBanc Capital Markets)
- TJX +4.4% (upgraded to Buy from Hold at Jefferies)
- CAMP +3.4% (upgraded to Buy from Hold at Jefferies)
- JNPR +2.6% (upgraded to Neutral from Sell at Goldman)